 |
|
Research Matters at the Arizona Health Sciences Center (AHSC): UA Researchers Seek Safer Cystic Fibrosis Test
September 10, 2009TUCSON, Ariz. - Researchers from The University of Arizona Colleges of Pharmacy and Medicine are teaming up to try to invent a novel non-invasive lung test for cystic fibrosis sufferers.
Eric Snyder, PhD, assistant professor at the UA College of Pharmacy, is the principal investigator on the study, "Quantification of Exhaled Condensate Using Bronchoalveolar Lavage in Cystic Fibrosis." Dr. Snyder will work with UA College of Medicine faculty members Cori Daines, MD, and Wayne Morgan, MD, on the project.
Cystic fibrosis (CF) is a disease that affects the lung. According to the Cystic Fibrosis Foundation, about 30,000 children and adults in the United States (70,000 worldwide) suffer from CF. The disease results from a genetic alteration that lowers the function of chloride channels in the lung, which leads to a dry lung. The drier a CF patient's lungs, the more dangerous his or her disease.
The fluctuations of sodium, potassium and chloride in the lung all are important in keeping the lung wet and are of particular importance in cystic fibrosis. Studies in the past using cell lines or animal tissues have shown that the administration of a common drug used in cystic fibrosis, a beta-agonist, increases the amount of chloride on cells and this should help keep the lungs wet. The problem is that currently no easy way exists to measure the amount of chloride on a person's lung cells to optimize his or her therapy.
Today, measuring what is on lung cells requires an invasive test called bronchoalveolar lavage. Although bronchoalveolar lavage typically is used to determine the level of disease severity by exploring inflammatory markers, Dr. Snyder notes that it also could be used to collect signs of chloride, and possibly lung dryness.
During bronchoalveolar lavage, the patient is anesthetized and a tube is inserted into the lung. Next, a small amount of water is sprayed into the lung's airway and then sucked out through the tube. This fluid then can be analyzed for a variety of factors.
Although bronchoalveolar lavage is not a common procedure, the technique is invasive and carries some risk. The aim of Dr. Snyder's study is to develop a safer, non-invasive procedure that can measure some of the data that can be taken with a bronchoalveolar lavage with comparable accuracy.
The non-invasive procedure that Dr. Snyder's research will explore involves measuring signs of lung dryness by using a patient's breath that is condensed in a cooling chamber. To do this, the team first will have a patient breathe into a machine in Dr. Snyder's laboratory in the College of Pharmacy. Breathing on this machine condenses the patient's breath in a cooling chamber so that the research team can measure the amount of sodium, potassium and chloride it contains. Immediately after this non-invasive test, the patient will go to University Medical Center for a bronchoalveolar lavage performed under the direction of Drs. Daines and Morgan.
Once the brochoalveolar lavage is completed, the team will compare the amount of sodium, potassium, and chloride ions gathered in that test to the amount gathered non-invasively in the breath test. This will allow the team to see if the non-invasive test is as accurate as the invasive technique.
"This research will provide data to further explore the development of a non-invasive tool to measure airway fluid composition," says Dr. Snyder. "It will provide important preliminary data for future, larger studies in this patient population. Our goal is to invent a non-invasive test that will aid in the assessment and treatment of cystic fibrosis."
The study is funded by a Faculty Small Grant Award of close to $10,000 from The University of Arizona Foundation. It will begin in September.
University of Arizona
The fluctuations of sodium, potassium and chloride in the lung all are important in keeping the lung wet and are of particular importance in cystic fibrosis. Studies in the past using cell lines or animal tissues have shown that the administration of a common drug used in cystic fibrosis, a beta-agonist, increases the amount of chloride on cells and this should help keep the lungs wet. The problem is that currently no easy way exists to measure the amount of chloride on a person's lung cells to optimize his or her therapy.
Today, measuring what is on lung cells requires an invasive test called bronchoalveolar lavage. Although bronchoalveolar lavage typically is used to determine the level of disease severity by exploring inflammatory markers, Dr. Snyder notes that it also could be used to collect signs of chloride, and possibly lung dryness.
During bronchoalveolar lavage, the patient is anesthetized and a tube is inserted into the lung. Next, a small amount of water is sprayed into the lung's airway and then sucked out through the tube. This fluid then can be analyzed for a variety of factors.
Although bronchoalveolar lavage is not a common procedure, the technique is invasive and carries some risk. The aim of Dr. Snyder's study is to develop a safer, non-invasive procedure that can measure some of the data that can be taken with a bronchoalveolar lavage with comparable accuracy.
The non-invasive procedure that Dr. Snyder's research will explore involves measuring signs of lung dryness by using a patient's breath that is condensed in a cooling chamber. To do this, the team first will have a patient breathe into a machine in Dr. Snyder's laboratory in the College of Pharmacy. Breathing on this machine condenses the patient's breath in a cooling chamber so that the research team can measure the amount of sodium, potassium and chloride it contains. Immediately after this non-invasive test, the patient will go to University Medical Center for a bronchoalveolar lavage performed under the direction of Drs. Daines and Morgan.
Once the brochoalveolar lavage is completed, the team will compare the amount of sodium, potassium, and chloride ions gathered in that test to the amount gathered non-invasively in the breath test. This will allow the team to see if the non-invasive test is as accurate as the invasive technique.
"This research will provide data to further explore the development of a non-invasive tool to measure airway fluid composition," says Dr. Snyder. "It will provide important preliminary data for future, larger studies in this patient population. Our goal is to invent a non-invasive test that will aid in the assessment and treatment of cystic fibrosis."
The study is funded by a Faculty Small Grant Award of close to $10,000 from The University of Arizona Foundation. It will begin in September.
University of Arizona
Cystic Fibrosis Current Events and Cystic Fibrosis News RSSCausative gene of a rare disorder discovered by sequencing only protein-coding regions of genome
For the first time, scientists have successfully used a method called exome sequencing to quickly discover a previously unknown gene responsible for a mendelian disorder.
Bacteria 'launch a shield' to resist attack
Researchers from the University of Copenhagen and the Technical University of Denmark along with other collaborators in Denmark and the US found that the bacterium Pseudomonas aeruginosa can 'switch on' production of molecules that kill white blood cells - preventing the bacteria being eliminated by the body's immune system.
Protein critical for insulin secretion may be contributor to diabetes
A cellular protein from a family involved in several human diseases is crucial for the proper production and release of insulin, new research has found, suggesting that the protein might play a role in diabetes.
New clinical guidelines for exacerbations in cystic fibrosis
The American Thoracic Society has released new clinical guidelines for the treatment of exacerbations in cystic fibrosis based on a review of the literature on current clinical practices.
Nanoparticle treatment for burns curbs infection, reduces inflammation
Treating second-degree burns with a nanoemulsion lotion sharply curbs bacterial growth and reduces inflammation that otherwise can jeopardize recovery, University of Michigan scientists have shown in initial laboratory studies.
Species diversity helps ASU researchers refine analyses of human gene mutations
In the new era of personalized medicine, physicians hope to provide earlier diagnoses and improve therapy by evaluating patients' genetic blueprints. But, as a new bioinformatics study emphasizes, the first step must be to correctly decipher the deluge of information locked in our DNA and determine its impact on human health.
New developments in reproductive medicine
Three out of ten women who undergo polar body diagnosis go on to have a child.
Faster, cheaper way to find disease genes in human genome passes initial test
University of Washington (UW) researchers have successfully developed a novel genome-analysis strategy for more rapid, lower cost discovery of possible gene-disease links.
Mutation responsible for cystic fibrosis also involved in muscle atrophy
Patients with cystic fibrosis (CF) usually experience significant muscle loss, a symptom traditionally considered to be a secondary complication of the devastating genetic disease.
Test helps in fight against lung infections and for treating other life-threatening infections
A new test developed by Edmonton-based Innovotech™ Inc. will now allow doctors to more accurately identify the right antibiotics required to treat serious, chronic infections that are biofilm based.
More Cystic Fibrosis Current Events and Cystic Fibrosis News Articles
 |
Cystic Fibrosis: A Guide for Patient and Family by David M Orenstein (Editor) Univ. of Pittsburgh, PA. Text is designed specifically for patients with cystic fibrosis and their families. Explains the disease process, outlines the fundamentals of diagnosing and screening, and addresses the challenges of treatment for those living with CF. Includes new material on carrier testing, infection control, and more. Previous edition: c1997. Softcover. |
 |
With Every Breath: stories by and about people living with cystic fibrosis by Katherine Russell and Margot Russell (Author), Katherine Russell and Margot Russell (Editor) Over 30,000 people in the US have cystic fibrosis, a life-threatening genetic disease that affects the lungs and digestive system. Physically, fighting it is a very perilous struggle. Emotionally, coping can oftentimes be even harder. With Every Breath consists of stories by and about people living with cystic fibrosis. Created to motivate, inspire, and generate positivity for those living with cystic fibrosis, this book is something you can open time and time again. Designed for all ages, this collection of diverse stories offers unique perspectives from patients, a CF doctor and nurse, and family members of those living with the illness. Patients aren't the only ones who will want to read With Every Breath as family members, friends, and doctors can all find inspiration when they... |
 |
Cystic Fibrosis: Everything You Need To Know (Your Personal Health) by Wayne Kepron MD FRCPC (Author) Cystic fibrosis afflicts approximately 30,000 Americans. The average age of survival has been steadily increasing, but not quickly enough: a child born with cystic fibrosis today can only expect to live 35 to 40 years. In this valuable new addition to the Your Personal Health series, Dr. Wayne Kepron offers a comprehensive look at the disease that afflicts so many young people. Topics include: - Symptoms of cystic fibrosis - Making a diagnosis - Complications of the disease - Treatments (including lung transplants) - Techniques and precautions in lung care - Transition into adulthood - Prospects for gene therapy - End-of-life issues Using diagrams, charts and case studies, Cystic Fibrosis is designed for patients, their families, and caregivers. It is both a quick... |
 |
Cystic Fibrosis (Facts) by Ann Harris (Author), Anne Thomson (Author) Cystic Fibrosis: The Facts provides a much needed simple and understandable source book about this disease. It is aimed at those living with Cystic Fibrosis (CF), either themselves or members of their families or their friends. The book explains clearly what is happening to the body in CF, what causes it and what treatment options are available for the different aspects of the disease. There are more detailed chapters for those wanting to find out about the genetics of the disease and specific aspects such as how it affects life choices and employment. It looks to the future in terms of potential new therapies for CF and provides useful information on organizations that can provide help and further information across those areas of the world where the disease is prevalent. |
 |
The Power of Two: A Twin Triumph over Cystic Fibrosis by Isabel Stenzel Byrnes; Anabel Stenzel (Author) The tragedy of cystic fibrosis has been touchingly recounted before, but this is the first book to portray the symbiotic relationship between twins who share this life-threatening disease through adulthood. Isabel Stenzel Byrnes and Anabel Stenzel tell of their struggle to pursue normal lives while grappling with the realization that they might die young. Their story reflects the physical and emotional challenges of a particularly aggressive form of CF and tells how the twins bicultural heritage Japanese and German influenced the way they coped. The Power of Two is an honest and gripping portrayal of day-to-day health care, the impact of chronic illness on marriage and family, and the importance of a support network to continuing survival. These two remarkable sisters have much to teach... |
 |
The Stones Applaud: How Cystic Fibrosis Shaped My Childhood by Teresa Anne Mullin (Author) Teresa Mullin was diagnosed with cystic fibrosis at four years of age, but it was not until she was nine that she learned most children with the disease were not expected to live to adulthood. What had been a nuisance soon became a force that molded her childhood, youth, and future. In The Stones Applaud, Mullin writes of absences from school, serving as a poster child, frequent hospitalizations, medical treatments, and most painful the isolation that came with cystic fibrosis, an inherited condition that damages the lungs and affects the digestive system. With dry humor and sharp insights, Mullin describes her battles with the disease, teachers, fellow students, and even medical professionals who tried to hold her back from experiencing life. Alternately funny, frank, poignant, and... |
 |
Cystic Fibrosis by Margaret Hodson (Author), Duncan Geddes (Author), Andrew Bush (Author) This international and authoritative work, which brings together current knowledge in the field of cystic fibrosis, has become established in previous editions as a leading reference in the field. The third edition continues to provide everything that the clinician or allied health professional treating patients with cystic fibrosis will need in a single manageable volume. Thoroughly revised and updated throughout, it reflects the significant advances that have been made in the field since the second edition published in 2000. Cystic Fibrosis outlines in detail the basic science that underlies the disease and its progression, putting it into a clinical context. Diagnostic and clinical aspects are covered in depth, as are monitoring the condition and the importance of... |
 |
Taking Cystic Fibrosis to School by Cynthia S. Henry (Author), Cynthia S. Henry (Author), Tom Dineen (Author), Tom Dineen (Illustrator) These beautifully illustrated and fun-to-read storybooks simplify and normalize complicated childhood conditions, like cystic fibrosis. When read aloud, other children can identify why a peer may be treated differently and begin to empathize with them. In addition, children whose conditions set them apart as being different begin to feel accepted and safe. Each book includes a Kids' Quiz to reinforce new information and Ten Tips for Teachers to provide additional facts and ideas for teacher use. In Taking Cystic Fibrosis to School, Jessie explains to her classmates that even though she has cystic fibrosis, she can still attend school. |
 |
Understanding Cystic Fibrosis (Understanding Health and Sickness Series) by Ph.D., Karen Hopkin (Author) Since the discovery of the CF gene in 1989, scientists have learned a great deal about the biology of this disease which strikes one child in every 3,300 births. With the gene pinpointed, scientists are now working on ways to replace it and are developing better tests for earlier diagnosis. Understanding CF charts the progress that has been made in a disease whose symptoms can range from mild respiratory distress to life-threatening lung infections |
 |
Little Brave Ones: For Children Who Battle Cystic Fibrosis by Carrie Lux (Author) See a day in the life of a preschooler with CF. |
| © 2009 BrightSurf.com |